Cargando…
Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina
IMPORTANCE: X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal genetic disorder in which an accumulation of very long-chain fatty acids leads to inflammatory demyelination in the central nervous system and to adrenal cortex atrophy. In 2016, X-ALD was added to the US Recommended Uniform Screenin...
Autores principales: | Lee, Stacey, Clinard, Kristin, Young, Sarah P., Rehder, Catherine W., Fan, Zheng, Calikoglu, Ali S., Bali, Deeksha S., Bailey, Donald B., Gehtland, Lisa M., Millington, David S., Patel, Hari S., Beckloff, Sara E., Zimmerman, Scott J., Powell, Cynthia M., Taylor, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042889/ https://www.ncbi.nlm.nih.gov/pubmed/32003821 http://dx.doi.org/10.1001/jamanetworkopen.2019.20356 |
Ejemplares similares
-
Current State of the Art of Newborn Screening for Lysosomal Storage Disorders
por: Millington, David S., et al.
Publicado: (2018) -
Newborn Screening for X-Linked Adrenoleukodystrophy
por: Moser, Ann B., et al.
Publicado: (2016) -
Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs
por: Millington, David S., et al.
Publicado: (2017) -
A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check
por: Kucera, Katerina S., et al.
Publicado: (2021) -
Sex‐specific newborn screening for X‐linked adrenoleukodystrophy
por: Albersen, Monique, et al.
Publicado: (2022)